Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Haman

Orthopaedic Trauma Lima, OH Medical Doctor

NPI 1073586020 CMS profile 365381

801 Medical Dr, Suite A, Lima, OH 45804

Open in the dashboard

General payments

$289,463

269 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Steven Haman of Lima, OH is reported in the CMS Open Payments database as having received $289,463 across 269 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $57,616 53
2024 General $53,762 59
2023 General $50,095 49
2022 General $55,592 49
2021 General $32,599 23
2020 General $54 1
2019 General $39,745 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Haman
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Steven Haman were reported at $57,616. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Steven Haman Orthopaedic Trauma median Middle half National median
2019 $39,745 $1,475 $264–$6,401 $163
2020 $54 $596 $120–$4,020 $114
2021 $32,599 $919 $171–$4,697 $132
2022 $55,592 $1,547 $272–$7,240 $149
2023 $50,095 $1,330 $247–$5,875 $160
2024 $53,762 $1,288 $277–$6,797 $164
2025 $57,616 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $268,253 242 payments
  2. Exactech, Inc. $11,295 7 payments
  3. Medical Device Business Services, Inc. $8,253 1 payment
  4. Stryker Corporation $1,309 12 payments
  5. Globus Medical, Inc. $202 3 payments
  6. Anika Therapeutics, Inc. $63 2 payments
  7. Zimmer Biomet Holdings, Inc. $54 1 payment
  8. Flower Orthopedics Coporation $35 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $173,279 22 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $66,250 7 payments
  3. Travel and Lodging $43,976 94 payments
  4. Food and Beverage $5,959 146 payments
Products named General payments · program years 2019–2025
  1. EVOS Trauma Plates, Screws, and Nails $150,935 87 payments
  2. TRIGEN INTERTAN $116,273 63 payments
  3. EVOS Trauma Plates, Screws, and Nails $70,089 21 payments
  4. TRIGEN META-NAIL $55,726 13 payments
  5. Cadence $44,972 7 payments
  6. JOURNEY II $32,750 4 payments
  7. Integra $30,477 5 payments
  8. TWINFIX $30,477 5 payments
  9. POLAR3 $29,125 3 payments
  10. JOURNEY II UK $29,125 3 payments
  11. Other $254,454 156 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

301

Median for Orthopedic Surgery: 203

Drug cost

$1,678

Median for Orthopedic Surgery: $1,433

Branded share of claims

45.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 99 $753
Methylprednisolone Generic 49 $292
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 24 $158
Cyclobenzaprine Hcl Generic 22 $129
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 14 $91
Meloxicam Generic 37 $89
Cephalexin Generic 35 $89
Tramadol Hcl Generic 21 $76

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 113 billing codes

Paid by Medicare

$196,768

Medicare's payments for the services billed

Medicare patients

372

Average age 78

Services billed

725

235 women, 137 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 43%
Chronic kidney disease 38%
Depression 37%
Diabetes 34%
Heart failure 34%
Atrial fibrillation 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

269 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record